发明名称 |
LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARRHALIS INFECTIONS IN MAMMALS |
摘要 |
A conjugate vaccine for Moraxella (Branhamella) catarrhalis comprising isolated lipooligosaccharide from which esterified fatty acids have been removed, to produce a detoxified lipooligosaccharide (dLOS), or from which lipid A has been removed, to produce a detoxified oligosaccharide (OS), which is linked to an immunogenic carrier. The vaccine is useful for preventing otitis media and respiratory infections caused by M. catarrhalis in mammals, including humans.
|
申请公布号 |
CA2315746(A1) |
申请公布日期 |
1999.07.22 |
申请号 |
CA19992315746 |
申请日期 |
1999.01.12 |
申请人 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SE CRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
发明人 |
ROBBINS, JOHN B.;GU, XIN-XING |
分类号 |
A61K39/02;A61K39/116;A61K39/295;A61K39/385;A61P27/16;A61P31/04;C08B37/00;C12P19/04;(IPC1-7):A61K39/02 |
主分类号 |
A61K39/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|